Abstract
Medical cannabis has received significant interest in recent years due to its promising benefits in the management of pain, anxiety, depression and neurological and movement disorders. Specifically, the major phytocannabinoids derived from the cannabis plant such as (-) trans-Δ9 -tetrahydrocannabinol (THC) and cannabidiol (CBD), have been shown to be responsible for the pharmacological and therapeutic properties. Recently, these phytocannabinoids have also attracted special attention in cancer treatment due to their well-known palliative benefits in chemotherapy-induced nausea, vomiting, pain and loss of appetite along with their anticancer activities. Despite the enormous pharmacological benefits, the low aqueous solubility, high instability (susceptibility to extensive first pass metabolism) and poor systemic bioavailability restrict their utilization at clinical perspective. Therefore, drug delivery strategies based on nanotechnology are emerging to improve pharmacokinetic profile and bioavailability of cannabinoids as well as enhance their targeted delivery. Here, we critically review the nano-formulation systems engineered for overcoming the delivery limitations of native phytocannabinoids including polymeric and lipid-based nanoparticles (lipid nano capsules (LNCs), nanostructured lipid carriers (NLCs), nanoemulsions (NE) and self-emulsifying drug delivery systems (SEDDS)), ethosomes and cyclodextrins as well as their therapeutic applications.
Keywords: cannabidiol; cannabinoids; drug delivery; medical cannabis; nanoformulations; tetrahydrocannabinol.
© 2023 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd.
Similar articles
-
The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.Eur J Pharm Sci. 2017 Nov 15;109:21-30. doi: 10.1016/j.ejps.2017.07.003. Epub 2017 Jul 20.PMID: 28736128
-
PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.J Pharm Sci. 2018 May;107(5):1423-1429. doi: 10.1016/j.xphs.2017.12.020. Epub 2017 Dec 26.PMID: 29287930
-
Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.J Control Release. 2017 Nov 28;266:1-7. doi: 10.1016/j.jconrel.2017.09.011. Epub 2017 Sep 8.PMID: 28890215 Clinical Trial.
-
It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets.Molecules. 2020 Sep 4;25(18):4036. doi: 10.3390/molecules25184036.PMID: 32899626 Free PMC article. Review.
-
Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.Adv Exp Med Biol. 2021;1264:29-45. doi: 10.1007/978-3-030-57369-0_3.PMID: 33332002 Review.
References
REFERENCES
-
- Aggarwal, S. K. (2016). Use of cannabinoids in cancer care: Palliative care. Current Oncology, 23(Suppl 2), S33-S36.
- Ainbinder, D., Paolino, D., Fresta, M., & Touitou, E. (2010). Drug delivery applications with ethosomes. Journal of Biomedical Nanotechnology, 6, 558-568.
- Ali, A., Ansari, V. A., Ahmad, U., Akhtar, J., & Jahan, A. (2017). Nanoemulsion: An advanced vehicle for efficient drug delivery. Drug Research, 67, 617-631.
- Andre, C. M., Hausman, J., & Guerriero, G. (2016). Cannabis sativa: The Plant of the Thousand and one Molecules. Frontiers. Plant Science, 7, 1-19.
- Andriotis, E. G., Chachlioutaki, K., Monou, P. K., Bouropoulos, N., Tzetzis, D., Barmpalexis, P., … Fatouros, D. G. (2021). Development of water-soluble electrospun fibers for the Oral delivery of cannabinoids. AAPS PharmSciTech, 22, 1-14.
Publication types
Grant support
LinkOut – more resources
-
Full Text Sources